Intratumoral delivery of the chitin-derived C100 adjuvant promotes robust STING, IFNAR, and CD8+ T cell-dependent anti-tumor immunity JL Turley, RW Ward, J Huete-Carrasco, N Muñoz-Wolf, K Roche, L Jin, ... Cell Reports Medicine 5 (5), 2024 | | 2024 |
Vaccine adjuvants: Tailoring innate recognition to send the right message EC Lavelle, CP McEntee Immunity 57 (4), 772-789, 2024 | | 2024 |
Immunotherapy for cancer E Lavelle, J Turley, R Ward US Patent App. 18/039,107, 2024 | | 2024 |
Editorial overview: The march of mucosal vaccines EC Lavelle, M Genescà Current opinion in immunology 86, 102408, 2024 | | 2024 |
Rational design of polymer‐based particulate vaccine adjuvants J Huete‐Carrasco, RI Lynch, RW Ward, EC Lavelle European Journal of Immunology 54 (2), 2350512, 2024 | | 2024 |
Bile acids induce IL-1α and drive NLRP3 inflammasome-independent production of IL-1β in murine dendritic cells E Oleszycka, EC O’Brien, M Freeley, EC Lavelle, A Long Frontiers in Immunology 14, 1285357, 2023 | 2 | 2023 |
Polymeric nanoparticles as vaccine adjuvants E Lavelle, N Munoz-wolf US Patent App. 17/787,051, 2023 | | 2023 |
Immunostimulatory nanoparticles go viral J Huete-Carrasco, EC Lavelle Nature Materials 22 (3), 273-275, 2023 | 2 | 2023 |
Non-canonical inflammasome activation mediates the adjuvanticity of nanoparticles N Munoz-Wolf, RW Ward, CH Hearnden, FA Sharp, J Geoghegan, ... Cell Reports Medicine 4 (1), 2023 | 18 | 2023 |
Myeloid cell–derived proteases produce a proinflammatory form of IL-37 that signals via IL-36 receptor engagement GP Sullivan, P Davidovich, N Muñoz-Wolf, RW Ward, ... Science Immunology 7 (78), eade5728, 2022 | 6 | 2022 |
Establishment of anti-inflammatory innate immune memory in macrophages by particles R Lynch, GL Aoife, S McCluskey, EC Lavelle EUROPEAN JOURNAL OF IMMUNOLOGY 52, 39-39, 2022 | | 2022 |
Enhancing antigen cross-presentation and CD8 (+) T cell responses by adsorbing antigen to nanoparticles J Huete-Carrasco, N Munoz-Wolf, RW Ward, EC Lavelle EUROPEAN JOURNAL OF IMMUNOLOGY 52, 4-4, 2022 | | 2022 |
Inflammasome activating nanoparticles promote protective anti-tumour CD8 (+) T cells R Ward, N Munoz-Wolf, EC Lavelle EUROPEAN JOURNAL OF IMMUNOLOGY 52, 25-25, 2022 | | 2022 |
Macrophage innate training induced by IL-4 and IL-13 activation enhances OXPHOS driven anti-mycobacterial responses MLE Lundahl, M Mitermite, DG Ryan, S Case, NC Williams, M Yang, ... Elife 11, e74690, 2022 | 23 | 2022 |
Resolving adjuvant mode of action to enhance vaccine efficacy JL Turley, EC Lavelle Current Opinion in Immunology 77, 102229, 2022 | 23 | 2022 |
Mucosal vaccines—fortifying the frontiers EC Lavelle, RW Ward Nature Reviews Immunology 22 (4), 236-250, 2022 | 449 | 2022 |
Immuno-modulatory biomaterials as anti-inflammatory therapeutics RI Lynch, EC Lavelle Biochemical Pharmacology 197, 114890, 2022 | 16 | 2022 |
Fatballs foster fabulous follicles JL Turley, EC Lavelle Immunity 54 (12), 2695-2697, 2021 | | 2021 |
A novel polymer-based STING activator with potent anti-tumour activity JL Turley, R Ward, M Andersson, EC Lavelle EUROPEAN JOURNAL OF IMMUNOLOGY 51, 396-396, 2021 | | 2021 |
Cyclosporine a modulates antifungal responses in CD103+ DCs A Liddicoat, E Lavelle EUROPEAN JOURNAL OF IMMUNOLOGY 51, 377-377, 2021 | | 2021 |